Free Trial
→ Wall Street Legend: “Global Market Freeze Coming” (From Weiss Ratings) (Ad)tc pixel Free XTLB Stock Alerts

XTL Biopharmaceuticals (XTLB) Stock Chart & Stock Price History

XTL Biopharmaceuticals logo
$1.98 -0.04 (-1.98%)
Closing price 10/7/2026 04:00 PM Eastern
Extended Trading
$2.00 +0.02 (+1.01%)
As of 10/7/2026 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

XTL Biopharmaceuticals Stock Price Performance

The XTL Biopharmaceuticals (XTLB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 94.30%, with a year-to-date return of -14.06%. In the past month, the stock has decreased 18.85%, reflecting recent market activity.

As of the latest close, XTL Biopharmaceuticals traded at $1.98 with a market cap of $4.69 million and volume of 27,816 shares. Five years ago, the stock traded at a split-adjusted price of $61.28, representing a 96.77% decrease over that period. At the time, it had a market cap of $19.69 million and a volume of 1,865 shares.

Receive XTLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-7.91%
1 Month
Performance
-18.85%
3 Month
Performance
-31.72%
Year-To-Date
Performance
N/A
1 Year
Performance
N/A
5 Year
Performance
-96.77%

XTLB Stock Chart for Thursday, October, 8, 2026

XTLB Chart by TradingView

XTL Biopharmaceuticals Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/07/2026$2.01$1.98
-1.49%		$2.05$1.9827,816 shs$4.69 million
10/06/2026$2.18$2.01
-7.80%		$2.26$2.0236,957 shs$4.76 million
10/05/2026$2.15$2.18
+1.40%		$2.36$2.1712,934 shs$5.17 million
10/02/2026$2.13$2.15
+0.94%		$2.21$2.166,740 shs$5.10 million
10/01/2026$2.31$2.13
-7.71%		$2.42$2.137,130 shs$5.05 million
09/30/2026$2.19$2.31
+5.39%		$2.33$2.301,561 shs$5.46 million
09/29/2026$2.41$2.19
-8.94%		$2.28$2.1124,250 shs$5.19 million
09/28/2026$2.29$2.41
+5.21%		$2.44$2.233,635 shs$5.70 million
09/25/2026$2.41$2.29
-5.15%		$2.43$2.201,039 shs$5.42 million
09/24/2026$2.27$2.41
+6.17%		$2.50$2.2213,107 shs$5.70 million
09/23/2026$2.29$2.27
-0.87%		$2.40$2.202,540 shs$5.38 million
09/22/2026$2.38$2.29
-3.78%		$2.27$2.27123 shs$5.43 million
09/21/2026$2.27$2.38
+4.85%		$2.38$2.19749 shs$5.63 million
09/18/2026$2.43$2.27
-6.39%		$2.40$2.352,996 shs$5.37 million
09/17/2026$2.39$2.43
+1.46%		$2.40$2.352,996 shs$5.75 million
09/16/2026$2.41$2.39
-0.99%		$2.49$2.381,730 shs$5.66 million
09/15/2026$2.49$2.41
-3.21%		$2.50$2.285,326 shs$5.71 million
09/14/2026$2.44$2.49
+2.30%		$2.51$2.402,216 shs$5.91 million
09/11/2026$2.36$2.44
+3.44%		$2.56$2.461,599 shs$5.78 million
09/10/2026$2.49$2.36
-5.46%		$2.56$2.406,260 shs$5.59 million
09/09/2026$2.44$2.49
+2.17%		$2.56$2.406,260 shs$5.50 million
09/08/2026$2.46$2.44
-0.61%		$2.53$2.53660 shs$5.78 million
Related Companies

This page (NASDAQ:XTLB) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
A dividend every week of the year
Most dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...
Market Savvy | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Look at Elon’s face after meeting with China
Elon Musk recently met with Chinese President Xi Jinping, and a former Wall Street Journal Personal Finance Ex...
International Living | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as Novemeber. It...
Weiss Ratings | Sponsoredtc pixel
Inside a Former Merrill Lynch Advisor's Income Playbook
A former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consisten...
Base Camp Trading | Sponsoredtc pixel